Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugs
AIM: Until the year 2000, allogeneic haematopoietic cell transplantation (HCT) was the standard treatment for young and fit chronic myeloid leukaemia (CML) patients. CML was the main indication for allogeneic HCT. The introduction of tyrosine kinase inhibitors changed the treatment of CML patients...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2024-05-01
|
| Sarja: | Swiss Medical Weekly |
| Linkit: | https://smw.ch/index.php/smw/article/view/3754 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|